Transfusion Support in Patients with Hematologic Disease: New and Novel Transfusion Modalities

Overview

Journal Semin Hematol

Specialty Hematology

Date 2019 Dec 15

PMID 31836027

Citations 1

Authors

Sandhya R Panch

Bipin N Savani

David F Stroncek

Affiliations

Soon will be listed here.

Citing Articles

The Prevalence of Transfusion-Transmitted Diseases Among Blood Donors in the Central Blood Bank in Makkah, Saudi Arabia.

Albshri M, Manikandan P, Allahyani M, Aljuaid A, Almehmadi M, Alzabeedi K Cureus. 2023; 15(11):e48881.

PMID: 38106789 PMC: 10724763. DOI: 10.7759/cureus.48881.

References

Lin Y, Saskin A, Wells R, Lenis M, Mamedov A, Callum J . Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes. Vox Sang. 2017; 112(1):79-86. DOI: 10.1111/vox.12455. View

Hendrickson J, Tormey C . Red Blood Cell Antibodies in Hematology/Oncology Patients: Interpretation of Immunohematologic Tests and Clinical Significance of Detected Antibodies. Hematol Oncol Clin North Am. 2016; 30(3):635-51. DOI: 10.1016/j.hoc.2016.01.006. View

Vichinsky E, Luban N, Wright E, Olivieri N, Driscoll C, Pegelow C . Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion. 2001; 41(9):1086-92. DOI: 10.1046/j.1537-2995.2001.41091086.x. View

Evers D, Middelburg R, de Haas M, Zalpuri S, de Vooght K, van de Kerkhof D . Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study. Lancet Haematol. 2016; 3(6):e284-92. DOI: 10.1016/S2352-3026(16)30019-9. View

Allen E, Srivastava K, Hsieh M, Fitzhugh C, Klein H, Tisdale J . Immunohaematological complications in patients with sickle cell disease after haemopoietic progenitor cell transplantation: a prospective, single-centre, observational study. Lancet Haematol. 2017; 4(11):e553-e561. PMC: 6311987. DOI: 10.1016/S2352-3026(17)30196-5. View

Saraf S, Oh A, Patel P, Jalundhwala Y, Sweiss K, Koshy M . Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease. Biol Blood Marrow Transplant. 2015; 22(3):441-8. DOI: 10.1016/j.bbmt.2015.08.036. View

Fasano R, Monaco A, Meier E, Pary P, Lee-Stroka A, Otridge J . RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management. Blood. 2010; 116(15):2836-8. PMC: 2974591. DOI: 10.1182/blood-2010-04-279372. View

Hendrickson J, Tormey C . Understanding red blood cell alloimmunization triggers. Hematology Am Soc Hematol Educ Program. 2016; 2016(1):446-451. PMC: 6142457. DOI: 10.1182/asheducation-2016.1.446. View

OSuoji C, Liem R, Mack A, Kingsberry P, Ramsey G, Thompson A . Alloimmunization in sickle cell anemia in the era of extended red cell typing. Pediatr Blood Cancer. 2013; 60(9):1487-91. DOI: 10.1002/pbc.24530. View

10.

Chou S, Jackson T, Vege S, Smith-Whitley K, Friedman D, Westhoff C . High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood. 2013; 122(6):1062-71. DOI: 10.1182/blood-2013-03-490623. View

11.

Flegel W, Gottschall J, Denomme G . Integration of red cell genotyping into the blood supply chain: a population-based study. Lancet Haematol. 2015; 2(7):e282-9. PMC: 4508019. DOI: 10.1016/S2352-3026(15)00090-3. View

12.

Chou S, Flanagan J, Vege S, Luban N, Brown R, Ware R . Whole-exome sequencing for genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv. 2018; 1(18):1414-1422. PMC: 5727856. DOI: 10.1182/bloodadvances.2017007898. View

13.

Kacker S, Ness P, Savage W, Frick K, Shirey R, King K . Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients. Transfusion. 2013; 54(1):86-97. PMC: 3758770. DOI: 10.1111/trf.12250. View

14.

Rosse W, Gallagher D, Kinney T, Castro O, Dosik H, Moohr J . Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood. 1990; 76(7):1431-7. View

15.

Tahhan H, Holbrook C, Braddy L, Brewer L, Christie J . Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion. 1994; 34(7):562-9. DOI: 10.1046/j.1537-2995.1994.34794330008.x. View

16.

Castro O, Sandler S, Houston-Yu P, Rana S . Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion. 2002; 42(6):684-90. DOI: 10.1046/j.1537-2995.2002.00126.x. View

17.

Fasano R, Meyer E, Branscomb J, White M, Gibson R, Eckman J . Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Transfus Med Rev. 2018; 33(1):12-23. DOI: 10.1016/j.tmrv.2018.07.003. View

18.

Sakhalkar V, Roberts K, Hawthorne L, McCaskill D, Veillon D, Caldito G . Allosensitization in patients receiving multiple blood transfusions. Ann N Y Acad Sci. 2005; 1054:495-9. DOI: 10.1196/annals.1345.072. View

19.

Ambruso D, GITHENS J, Alcorn R, Dixon D, Brown L, Vaughn W . Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion. 1987; 27(1):94-8. DOI: 10.1046/j.1537-2995.1987.27187121485.x. View

20.

Wagner F . Screening Donors for Rare Antigen Constellations. Transfus Med Hemother. 2010; 36(3):199-203. PMC: 2980528. DOI: 10.1159/000218110. View